ILK and neoplasm: Following interaction with NET-DNA, this receptor was reported to activate integrin-linked kinase (ILK) that in turn recruits β-parvin and initiates the RAC1–CDC42 cascade to induce cytoskeleton rearrangement and directional migration of tumor cells.